Diagnostic accuracy of the bronchodilator response in children

J Allergy Clin Immunol. 2013 Sep;132(3):554-559.e5. doi: 10.1016/j.jaci.2013.03.031. Epub 2013 May 14.

Abstract

Background: The bronchodilator response (BDR) reflects the reversibility of airflow obstruction and is recommended as an adjunctive test to diagnose asthma. The validity of the commonly used definition of BDR, a 12% or greater change in FEV1 from baseline, has been questioned in childhood.

Objectives: We sought to examine the diagnostic accuracy of the BDR test by using 3 large pediatric cohorts.

Methods: Cases include 1041 children with mild-to-moderate asthma from the Childhood Asthma Management Program. Control subjects (nonasthmatic and nonwheezing) were chosen from Project Viva and Home Allergens, 2 population-based pediatric cohorts. Receiver operating characteristic curves were constructed, and areas under the curve were calculated for different BDR cutoffs.

Results: A total of 1041 cases (59.7% male; mean age, 8.9 ± 2.1 years) and 250 control subjects (46.8% male; mean age, 8.7 ± 1.7 years) were analyzed, with mean BDRs of 10.7% ± 10.2% and 2.7% ± 8.4%, respectively. The BDR test differentiated asthmatic patients from nonasthmatic patients with a moderate accuracy (area under the curve, 73.3%). Despite good specificity, a cutoff of 12% was associated with poor sensitivity (35.6%). A cutoff of less than 8% performed significantly better than a cutoff of 12% (P = .03, 8% vs 12%).

Conclusions: Our findings highlight the poor sensitivity associated with the commonly used 12% cutoff for BDR. Although our data show that a threshold of less than 8% performs better than 12%, given the variability of this test in children, we conclude that it might be not be appropriate to choose a specific BDR cutoff as a criterion for the diagnosis of asthma.

Keywords: AUC; Area under the curve; Asthma; BDR; Bronchodilator response; CAMP; Childhood Asthma Management Program; bronchodilator response; diagnosis.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Asthma / diagnosis*
  • Asthma / physiopathology
  • Bronchodilator Agents*
  • Budesonide*
  • Child
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Nedocromil*
  • Sensitivity and Specificity

Substances

  • Bronchodilator Agents
  • Nedocromil
  • Budesonide

Grants and funding